Position
Executive Chairman and CEO
Experience
Dr. John Climax is one of co-founders of ICON plc, one of the world’s largest contract research organizations. Dr. Climax was ICON plc’s Chairman from November 2002 to December 2009. Prior to that, from June 1990 to November 2002 he served as Chief Executive of the Company. He has over 25 years of experience in the contract research industry globally. Dr. Climax received his primary degree in pharmacy in 1977 from the University of Singapore, his masters in applied pharmacology in 1979 from the University of Wales and his PhD in clinical pharmacology from the National University of Ireland in 1982. He has authored a significant number of papers and presentations, and holds adjunct professorship at the Royal College of Surgeons of Ireland.
Position
Non-Executive Director Science / Strategy
Experience
Dr. Ronan Lambe, one of the Company’s co-founders, is a scientific advisor in addition to Board member.
Dr. Lambe also co-founded ICON plc (NASDAQ listed) and served as Chairman of the Board of the Company from June 1990 to November 2002. He has been a non executive director of ICON plc since January 2008.
Dr. Lambe has over 30 years experience in the contract research industry. Dr. Lambe attended the National University of Ireland where he received his Bachelor of Science degree in chemistry in 1959, his masters in biochemistry in 1962 and his PhD. in pharmacology in 1976.
Experience
Ms. Jane Hollingsworth is currently Executive Chair of Talee Bio, a gene therapy company focused on cystic fibrosis as well as diseases of the lung, and Managing Partner of Militia Hill Ventures.
Jane is co-founder and former Chief Executive Officer of NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on diseases of the central nervous system which was sold to Teva in 2014. She also co-founded and served as Executive Vice President of Auxilium Pharmaceuticals (NASDAQ: AUXL), a biopharmaceutical company focused on urology which was sold to Endo Pharmaceuticals in 2015. Prior to launching and leading these two successful biopharmaceutical companies, Jane was VP, Secretary & General Counsel of IBAH, Inc. (NASDAQ: IBAH), a multinational clinical research organization.
Position
Scientific Advisor
Experience
Dr. Mehar S. Manku has been active in lipid research for approximately forty years. During his lengthy career, Dr. Manku has authored some 250 scientific and technical papers, and is the named inventor on 20 patents. Dr. Manku served for 35 years as an executive editor of the fatty acid journal Prostaglandin, Leukotrienes and Essential Fatty Acids (PLEFAs). He was appointed Editor in 2003, and held the position until late 2010, when he stood down to become Emeritus Editor. Recently, he was appointed Editor-in-Chief of Medical Hypotheses. Dr. Manku worked in several research and development roles at Amarin Corporation from November 2004 to April 2010. Prior to Amarin, Dr. Manku worked in various scientific and technical roles at Scotia Pharmaceuticals Ltd and later at Laxdale Ltd (1979 – 2001). Dr. Manku currently holds the title of Honorary Professor at Aston University in Birmingham.
Position
Non-Executive Director Strategic Development
Experience
Mr. Alan Cooke has extensive experience in the healthcare and pharmaceutical market, and previously held positions of Chief Finanical Officer and Chief Executive Officer of the Trulife Group Limited.
Mr. Cooke has held a number of senior positions including President, Chief Operating Officer and Chief Financial Officer of Amarin Corporation plc. and Vice President, Global Strategic Planning of Elan Corporation plc. Mr. Cooke is Chairman of the Trinity College Institute of Neuroscience.